M2 Presswire - In- Depth Research on Biovail Corp.
M2 PRESSWIRE-3 April 2007-Biotech News: In- Depth Research on Biovail Corp(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:03042007 In- Depth Research on Biovail Corp (NYSE:BVF) Biovail Corporation engages in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing various drug-delivery technologies in the United States and Canada.
Related Results
Fort Lauderdale, Fla.-Based Drug Maker’s Shares Increase.(Knight Ridder/Tribu…
Biovail Reports Record Second Quarter 2001 Results.
Fort Lauderdale, Fla.-Based Drug Maker Welcomes Financial Turnaround.(Knight …
Indiana Consumers Will Share in Settlement over Blood-Pressure Medication.
Biovail Files Cardizem LA NDA for Angina.
The company principally focuses on central nervous system disorders, pain management, and cardiovascular diseases. It offers Zovirax Cream, an antiviral medication, for the treatment of herpes …
Read the rest of this article with a Free Trial at HighBeam Research.
